OVARIAN LOW GRADE SEROUS ADENOCARCINOMA
Clinical trials for OVARIAN LOW GRADE SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN LOW GRADE SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN LOW GRADE SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to block cancer growth in RAS-Mutant tumors
Disease control OngoingThis phase II trial is testing whether combining two targeted drugs, palbociclib and binimetinib, can help people with cancers that have RAS mutations. The study includes patients with pancreatic cancer, ovarian cancer, and other solid tumors. Researchers want to see if the drug …
Matched conditions: OVARIAN LOW GRADE SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for rare ovarian cancer: could hormone therapy replace chemo?
Disease control OngoingThis study tests whether the hormone therapy letrozole alone works as well as chemotherapy (paclitaxel and carboplatin) followed by letrozole for people with stage II-IV low-grade serous ovarian, fallopian tube, or peritoneal cancer. About 450 participants will be randomly assign…
Matched conditions: OVARIAN LOW GRADE SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC